The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.50
Bid: 45.00
Ask: 46.00
Change: 2.50 (5.81%)
Spread: 1.00 (2.222%)
Open: 43.10
High: 45.75
Low: 43.10
Prev. Close: 43.00
AVCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Tern raises GBP6 million; Kromek revenue down

Wed, 14th Jul 2021 11:30

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Symphony Environmental Technologies, up 11% at 21.17 pence, 12-month range 10.65p-47.0p. The anti-microbial plastic technologies firm receives approval from the US Food & Drug Administration for its d2p antimicrobial food contact technology.

----------

88 Energy, up 7.9% at 1.89p, 12-month range 0.24p-4.70p. The Alaska-focused oil exploration and appraisal company says additional phase one geochemical analysis of fluid extracts from Merlin-1 well core samples again demonstrates the presence of hydrocarbons. Results from phase two of side-wall core trim analysis are expected in the next few weeks. Phase two is designed to confirm not only the presence of oil but also the nature of the source rock, to help understand the likely quality of the oil as well as migration pathways.

----------

Alpha FX Group, up 6.7% at 1,665.00p, 12-month range 677p-1,720p. The foreign exchange risk management and international payments firm says trading in the first half ended June 30 has been "strong" across its business, with revenue up 89% year on year at GBP34 million. Adds 84 new clients and notes average revenue per client continued to increase. The company expects to exceed current internal expectations for 2021, on the back of continued strong trading. In 2020, saw revenue of GBP46.2 million with pretax profit of GBP17.1 million.

----------

Avacta, up 5.9% at 143.56p, 12-month range 88.66p-291.80p. The developer of diagnostics and cancer therapies says Life Sciences unit gets ISO 13485 certification for the quality management system for the manufacture and distribution of Affimer reagents for use in lateral flow, ELISA and immunodiagnostic in-vitro diagnostic devices.

----------

Fulcrum Utility Services, up 5.6% at 32.74p, 12-month range 28.25p-43.60p. The energy and multi-utility services provider wins new GBP4.9 million multi-utility infrastructure contract from unnamed "large investor developer", for a "major" new employment park in the West Midlands. As part of the contract, the company will design and install a high voltage primary substation and the electricity, water, and gas infrastructure to "energise and power" the new development.

----------

AIM - LOSERS

----------

Tern, down 13% at 19.40p, 12-month range 5.50p-31.67p. The investment firm completes fundraise at the issue price of 18.8p per share. The retail offer and subscription were both oversubscribed and the company said it raised GBP2 million and GBP4 million, respectively. "We intend to utilise the proceeds to maximise the value to our shareholders of our portfolio, and I look forward to providing further updates in due course," says Chief Executive Al Sisto.

----------

Kromek Group, down 7.0% at 15.00p, 12-month range 7.66p-25.20p. The detection technology firm says revenue totalled GBP10.4 million for the financial year that ended April 30 versus GBP13.1 million the year before. Pretax loss, however, narrows to GBP6.3 million from GBP18.3 million loss the year prior. This is due to non-repeat of GBP13.1 million of exceptional impairment losses on trade receivables and amounts recoverable on contracts. Separately, Kromek says it wins new contracts and orders across all segments for delivery this year.

----------

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
7 Sep 2020 14:28

IN BRIEF: Avacta To Launch SARS-CoV-2 Elisa Laboratory Test

IN BRIEF: Avacta To Launch SARS-CoV-2 Elisa Laboratory Test

Read more
7 Sep 2020 12:55

Avacta launching Covid-19 laboratory test

(Sharecast News) - Biotherapeutics company Avacta Group announced on Monday that it will launch an 'ELISA' laboratory test for the SARS-CoV-2 spike protein, to support global research efforts into the coronavirus that causes Covid-19.

Read more
2 Sep 2020 15:50

IN BRIEF: Avacta Expands Covid-19 Saliva Test Manufacturing Capacity

IN BRIEF: Avacta Expands Covid-19 Saliva Test Manufacturing Capacity

Read more
2 Sep 2020 13:37

Avacta signs Covid-19 test manufacturing deal with Abingdon

(Sharecast News) - Biotherapeutics company Avacta Group has entered into an agreement with Abingdon Health for the manufacture of its saliva-based rapid SARS-CoV-2 antigen test, it announced on Wednesday, as part of its ongoing expansion of manufacturing capacity.

Read more
18 Aug 2020 10:39

Avacta Expands Development Agreement With LG Chem Life Sciences

Avacta Expands Development Agreement With LG Chem Life Sciences

Read more
17 Aug 2020 20:07

IN BRIEF: Avacta Not Involved With Medusa 19's Covid Antibody Test

IN BRIEF: Avacta Not Involved With Medusa 19's Covid Antibody Test

Read more
11 Aug 2020 14:18

IN BRIEF: Avacta Names New Life Sciences Chief Development Officer

IN BRIEF: Avacta Names New Life Sciences Chief Development Officer

Read more
7 Aug 2020 11:11

Avacta to collaborate with Liverpool School of Tropical Medicine on Covid-19 test

(Sharecast News) - Avacta Group has entered into a collaboration with the Liverpool School of Tropical Medicine (LSTM), it announced on Friday, to clinically validate the rapid saliva-based coronavirus antigen test it is developing with Cytiva.

Read more
7 Aug 2020 10:45

UK WINNERS & LOSERS SUMMARY: Hikma Shines After Raising Sales Guidance

UK WINNERS & LOSERS SUMMARY: Hikma Shines After Raising Sales Guidance

Read more
7 Aug 2020 09:53

Avacta Collaborates With Liverpool School For Covid-19 Test Validation

Avacta Collaborates With Liverpool School For Covid-19 Test Validation

Read more
6 Aug 2020 14:58

IN BRIEF: Avacta Appoints BBI Solutions To Manufacture Covid Test Kit

IN BRIEF: Avacta Appoints BBI Solutions To Manufacture Covid Test Kit

Read more
6 Aug 2020 10:39

Avacta appoints BBI Solutions as manufacturing partner for Covid-19 antigen test

(Sharecast News) - Biotechnology company Avacta on Thursday appointed BBI Solutions as a manufacturing partner for the development of its rapid SARS-CoV-2 antigen test.

Read more
29 Jul 2020 19:01

IN BRIEF: Avacta Expands Partnership With Daewoong Pharmaceutical

IN BRIEF: Avacta Expands Partnership With Daewoong Pharmaceutical

Read more
29 Jul 2020 13:46

Avacta expands partnership with Daewoong to Covid-19 therapy

(Sharecast News) - Biotherapeutics and reagents developer Avacta Group announced an expansion of its collaboration and license agreement with Daewoong Pharmaceutical and AffyXell Therapeutics - the joint venture established in South Korea by the two companies - to develop stem cell treatments on Wednesday.

Read more
22 Jul 2020 17:57

UK TRADING UPDATE SUMMARY: Virus Hits Mears But Tristel Gets Boost

UK TRADING UPDATE SUMMARY: Virus Hits Mears But Tristel Gets Boost

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.